Chicago, Illinois-based Ventas, Inc. (VTR) is a real estate investment trust (REIT) that specializes in owning and managing a diverse portfolio of properties. Valued at a market cap of $42.4 billion, the company provides essential infrastructure for the longevity economy, offering products and services that center on senior housing communities, outpatient medical buildings, research centers, and triple-net leased healthcare facilities.
This healthcare REIT has outperformed the broader market over the past 52 weeks. Shares of VTR have rallied 33.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 30.6%. Moreover, on a YTD basis, the stock is up 12.8%, compared to SPX’s 8.1% rise.
Zooming in further, VTR’s outperformance looks more pronounced when compared to the State Street Real Estate Select Sector SPDR ETF’s (XLRE) 6.9% uptick over the past 52 weeks and 10.2% rise on a YTD basis.
On Apr. 27, shares of VTR surged 1.3% after its better-than-expected Q1 earnings release. The company’s revenue increased 22% year-over-year to $1.7 billion, topping analyst estimates by 5.1%. Moreover, its normalized FFO of $0.94 grew 9% from the year-ago quarter, exceeding consensus estimates of $0.91.
For the current fiscal year, ending in December, analysts expect VTR’s FFO to grow 10.6% year over year to $3.85. The company’s FFO surprise history is promising. It met or topped the consensus estimates in each of the last four quarters.
Among the 21 analysts covering the stock, the consensus rating is a "Strong Buy,” which is based on 16 “Strong Buy,” one “Moderate Buy,” and four "Hold” ratings.
The configuration has remained consistent over the past three months.
On May 7, KeyBanc maintained an “Overweight” rating on VTR and raised its price target to $95, indicating a 7.3% potential upside from the current levels.
The mean price target of $95.50 suggests a 7.9% premium to its current price levels, while its Street-high price target of $102 implies a 15.2% potential upside.
On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
- After Major Layoffs, Block Stock Is Staging a Turnaround. CEO Jack Dorsey Says AI Is Leading the Way.
- This Analyst Just Raised the Price Target on Coherent Stock by 50%. What to Know.
- CoreWeave Stock Falls as the AI Growth Story Slows Down
- A Major Catalyst for AAPL Stock Is Just a Month Away: Apple Is a ‘Sleep Tech Giant’ Says Wedbush
